4.1375
price down icon9.17%   -0.4425
 
loading

Bioatla Inc (BCAB) 最新ニュース

pulisher
Jun 25, 2026

Price to sales forward of BioAtla, Inc. – NASDAQ:BCAB - TradingView

Jun 25, 2026
pulisher
Jun 25, 2026

Enterprise value to revenue forward of BioAtla, Inc. – NASDAQ:BCAB - TradingView

Jun 25, 2026
pulisher
Jun 25, 2026

BioAtla, Inc. Actuals & Estimates (NASDAQ:BCAB) - TradingView

Jun 25, 2026
pulisher
Jun 25, 2026

BCAB Forecast — Price Target — Prediction for 2027 - TradingView

Jun 25, 2026
pulisher
Jun 24, 2026

BioAtla: BioAtla, Inc.Reverse Split Option Symbol: BCAB New Symbol: BCAB1 - Moomoo

Jun 24, 2026
pulisher
Jun 22, 2026

Bioatla Inc (BCAB) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey

Jun 22, 2026
pulisher
Jun 21, 2026

BCAB Q4 2025 Earnings: Narrower-than-Expected Loss Surprises; Shares Edge HigherMargin Compression Risk - dars.gov.et

Jun 21, 2026
pulisher
Jun 18, 2026

Bioatla Inc (BCAB) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey

Jun 18, 2026
pulisher
Jun 18, 2026

Bioatla Inc (BCAB) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey

Jun 18, 2026
pulisher
Jun 18, 2026

Bioatla Inc (BCAB) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey

Jun 18, 2026
pulisher
Jun 17, 2026

Bioatla Inc (BCAB) Financial Health: Profitability & Balance Sheet Analysis - TradingKey

Jun 17, 2026
pulisher
Jun 17, 2026

Bioatla Inc (BCAB) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey

Jun 17, 2026
pulisher
Jun 17, 2026

Bioatla Inc (BCAB) Valuation: PE, PB & Fair Value Analysis - TradingKey

Jun 17, 2026
pulisher
Jun 17, 2026

Bioatla Inc (BCAB) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey

Jun 17, 2026
pulisher
Jun 17, 2026

Bioatla Inc (BCAB) Institutional Confidence - TradingKey

Jun 17, 2026
pulisher
Jun 12, 2026

BCAB Q4 2025 Earnings: Narrower-than-Expected Loss Drives Positive Stock ReactionEPS Consistency Score - newsline.com

Jun 12, 2026
pulisher
Jun 12, 2026

BCAB Q4 2025 Earnings: Narrower Loss Surprises, Shares RiseLow Estimate Range - newsline.com

Jun 12, 2026
pulisher
Jun 11, 2026

BioAtla Inc. (BCAB) Slips 2.5% as Shares Test Key Support ZoneBearish Pattern Stocks - newsline.com

Jun 11, 2026
pulisher
Jun 07, 2026

BioAtla (BCAB) Slips 4.58% as Stock Nears Critical Support LevelTotal Put Call - newsline.com

Jun 07, 2026
pulisher
Jun 07, 2026

BioAtla Inc. (BCAB) Drops 4.58% as Stock Hovers Near Key Support LevelArms Index - dars.gov.et

Jun 07, 2026
pulisher
Jun 06, 2026

BCAB Q4 2025 Earnings: Narrower-Than-Expected Loss Offers Partial Offset Amid Stock DeclineAnalyst Consensus Shift - newsline.com

Jun 06, 2026
pulisher
Jun 06, 2026

BCAB Q4 2025 Earnings: Narrower-than-Expected Loss Highlights Cost Discipline Amid Pipeline ProgressROA Comparison - newsline.com

Jun 06, 2026
pulisher
Jun 05, 2026

BioAtla (NASDAQ: BCAB) CFO logs non-sale share withholdings for RSU taxes - Stock Titan

Jun 05, 2026
pulisher
Jun 05, 2026

BioAtla (BCAB) CMO has 494 shares withheld to cover RSU taxes - Stock Titan

Jun 05, 2026
pulisher
Jun 04, 2026

BCAB Q4 2025 Earnings: Narrower-Than-Expected Loss Highlights Cost DisciplineHigh Estimate Range - dars.gov.et

Jun 04, 2026
pulisher
Jun 03, 2026

BioAtla (NASDAQ: BCAB) schedules 2026 virtual meeting and pay vote - Stock Titan

Jun 03, 2026
pulisher
Jun 03, 2026

BCAB Q4 2025 Earnings: Narrower-Than-Expected Loss Driven by Operational DisciplineEarnings Whisper Number - newsline.com

Jun 03, 2026
pulisher
May 29, 2026

BioAtla Inc. (BCAB) Slips Nearly 3% as Biotech Sector Faces HeadwindsProfitability Factor - The Legal Advocate

May 29, 2026
pulisher
May 29, 2026

BCAB Q4 2025 Earnings: EPS Surprise and Pipeline Focus Drive Positive SentimentEarnings Outlook Update - newsline.com

May 29, 2026
pulisher
May 28, 2026

BioAtla Inc. (BCAB) Edges Higher as Stock Tests Key Resistance Near $3.95Schiff Line - The Legal Advocate

May 28, 2026
pulisher
May 27, 2026

BCAB Q4 2025 Earnings: Narrower-Than-Expected Loss Drives Positive SentimentRevenue Surprise History - newsline.com

May 27, 2026
pulisher
May 26, 2026

BCABBioAtla Inc Stock Price and Quote - Finviz

May 26, 2026
pulisher
May 26, 2026

BCAB Technical Analysis | Trend, Signals & Chart Patterns | BIOATLA INC (NASDAQ:BCAB) - ChartMill

May 26, 2026
pulisher
May 22, 2026

BCAB Stock Price, Quote & Chart | BIOATLA INC (NASDAQ:BCAB) - ChartMill

May 22, 2026
pulisher
May 21, 2026

BioAtla (BCAB) Q4 2025 Earnings: EPS $-8.00 Beats EstimatesStrong Earnings Momentum - The Legal Advocate

May 21, 2026
pulisher
May 19, 2026

Context Therapeutics Enters into License Agreement Amendment with BioAtla for CT-202 - Sahm

May 19, 2026
pulisher
May 19, 2026

Context Therapeutics Secures Full Rights to CT-202 from BioAtla with License Buyout, Phase 1 Trial Planned for Q3 2026 - Minichart

May 19, 2026
pulisher
May 18, 2026

Context Therapeutics Secures Full Rights to CT-202 Under Revised BioAtla Deal - Moomoo

May 18, 2026
pulisher
May 18, 2026

Context Therapeutics Pays $6.5 Million to Make BioAtla Antibody Licenses Perpetual and Royalty-Free - TradingView

May 18, 2026
pulisher
May 18, 2026

Context Therapeutics enters into license agreement amendment with BioAtla for CT-202 - marketscreener.com

May 18, 2026
pulisher
May 18, 2026

Context Therapeutics (CNTX) secures fully paid-up, non-terminable CT-202 license - Stock Titan

May 18, 2026
pulisher
May 17, 2026

The real story behind BioAtla BCAB valuation 333 20260507Margin Improvement Report - newsline.com

May 17, 2026
pulisher
May 15, 2026

BioAtla (BCAB) slashes R&D, flags going-concern risk amid cash crunch - Stock Titan

May 15, 2026
pulisher
May 15, 2026

BioAtla, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com

May 15, 2026
pulisher
May 14, 2026

Number of shareholders of BioAtla, Inc. – NASDAQ:BCAB - TradingView

May 14, 2026
pulisher
May 14, 2026

BioAtla (BCAB) Stock Analysis: +2.61% Gain — What to Watch 2026-05-14Continuation Pattern - newser.com

May 14, 2026
pulisher
May 12, 2026

BCAB Q1'26 Earnings: EPS estimate is (10.00) USD - TradingView

May 12, 2026
pulisher
May 11, 2026

TradingKey - TradingKey

May 11, 2026
pulisher
May 07, 2026

The real story behind BioAtla (BCAB) valuation (-3.33%) 2026-05-07Quote Data - Newser

May 07, 2026
pulisher
May 05, 2026

BCAB BioAtla delivers narrower than expected Q4 2025 loss, shares gain nearly two percent today.Social Trade Signals - newser.com

May 05, 2026
pulisher
May 01, 2026

Why is BioAtla (BCAB) stock gaining attention recently | Q4 2025: Better Than ExpectedMarket Hype Signals - Newser

May 01, 2026
pulisher
Apr 30, 2026

BioAtla, Inc. Executive Compensation, Governance, and Board Diversity Overview 2025 - Minichart

Apr 30, 2026
pulisher
Apr 29, 2026

Executive pay, board and share data detailed in BioAtla (NASDAQ: BCAB) 10-K/A - Stock Titan

Apr 29, 2026
pulisher
Apr 29, 2026

Is BioAtla (BCAB) stock reacting to key levels | Q4 2025: Earnings Beat EstimatesGeographic Revenue Trends - The Legal Advocate

Apr 29, 2026
pulisher
Apr 24, 2026

BioAtla to implement 50-for-1 share consolidation - MSN

Apr 24, 2026
$112.94
price up icon 1.53%
$35.27
price up icon 0.23%
$57.86
price up icon 1.65%
$78.94
price down icon 3.59%
ONC ONC
$306.25
price down icon 0.90%
$190.47
price up icon 0.31%
大文字化:     |  ボリューム (24 時間):